G12Di INCB161734 (zecdarasib; @Incyte) showed🔥ORRs of 89% w mFFX (n=27) and 69% (n=26) w GnP in 1L mPDAC, w/o concerning safety signals, presented today at #ESMO26. 👏View quoted post on X
Adds to other👍early ORR data in 1L mPDAC
- zoldon/FFX: 82%
- zoldon/GnP: 61%
- darax/GnP: 59%
- darax: 47%
Jeremy Kratz
@JeremyKratz
physician scientist of liver and pancreatic cancers, husband, father, recovering wolverine.
328 Following 422 Followers 295 Posts
Latest posts 5
Missing #badgerchallenge today yet #AACRpan26 going strong-> finalizing new trials @UWCarbone @PanCAN
Great to present our work in HCC and CCA @curecc at #AVAHO26 winning two best in session presentations w MCP student Trenton Testerman. #mentorship
Thanks @fox6now for having me to review recent KRAS inhibitor daraxonrasib FDA approved in #pancreaticcancer @PanCAN @PanCANChicago @UWCarbone fox6now.com/video/fmc-n5kk…
post @RevMedicines daraxonrasib approval time to implement #precisiononcology -> TODAY in Madison @UWCarbone @UW_CPM @Dr_R_Kurzrock @lungmedonc @DocDustyD advancingprecisionmedicine.com/ape-apo-event-…